Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

NCT07057427 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

812

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Nab paclitaxel
DRUG: Docetaxel and Carboplatin
DRUG: Trastuzumab + Pertuzumab

Sponsor

Henan Cancer Hospital